318 results
8-K/A
ABBV
Abbvie Inc
8 May 24
Departure of Directors or Certain Officers
5:00pm
A. Gonzalez
Susan E. Quaggin
Rebecca B. Roberts
Glenn F. Tilton
The stockholders ratified the appointment of Ernst & Young LLP as AbbVie’s independent
DEFA14A
ABBV
Abbvie Inc
18 Mar 24
Additional proxy soliciting materials
4:17pm
as AbbVie’s independent registered public accounting firm for 2024 For 3. Say on Pay – An advisory vote on the approval of executive compensation For 4
8-K
EX-1.1
43rg rqpcqe
26 Feb 24
Other Events
5:08pm
424B5
zl5qw4of
26 Feb 24
Prospectus supplement for primary offering
6:12am
S-8
EX-4.5
76xthr 5na
22 Feb 24
Registration of securities for employees
5:50pm
S-8
EX-23.2
7ir u9o5tzluwe4xe
22 Feb 24
Registration of securities for employees
5:50pm
S-8
3qmxdwcejf7t5etkyi
22 Feb 24
Registration of securities for employees
5:50pm
424B5
kogzsj i0heiua1
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
2vwyo4kk3ox0qlxxo73
20 Feb 24
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
9:00am
8-K
EX-99.1
07lk3joqet7z d1eir
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
8-K
7jfxj1
12 Oct 23
Departure of Directors or Certain Officers
5:17pm
11-K
2405ry
28 Jun 23
Annual report of employee stock purchases
5:00pm